Laboratory Co. of America Holdings (NYSE:LH) Shares Bought by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in Laboratory Co. of America Holdings (NYSE:LHFree Report) by 15.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,815 shares of the medical research company’s stock after purchasing an additional 2,363 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Laboratory Co. of America were worth $3,582,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Roundview Capital LLC increased its position in shares of Laboratory Co. of America by 1.6% in the first quarter. Roundview Capital LLC now owns 7,793 shares of the medical research company’s stock worth $2,055,000 after acquiring an additional 124 shares in the last quarter. LSV Asset Management increased its holdings in Laboratory Co. of America by 1.2% in the 1st quarter. LSV Asset Management now owns 34,800 shares of the medical research company’s stock valued at $9,175,000 after purchasing an additional 400 shares in the last quarter. Synovus Financial Corp raised its position in Laboratory Co. of America by 105.7% in the first quarter. Synovus Financial Corp now owns 1,654 shares of the medical research company’s stock valued at $441,000 after purchasing an additional 850 shares during the period. Cibc World Market Inc. acquired a new stake in shares of Laboratory Co. of America in the first quarter valued at about $213,000. Finally, Sei Investments Co. lifted its position in Laboratory Co. of America by 18.9% during the 1st quarter. Sei Investments Co. now owns 89,167 shares of the medical research company’s stock worth $23,543,000 after acquiring an additional 14,186 shares in the last quarter. Hedge funds and other institutional investors own 89.37% of the company’s stock.

Laboratory Co. of America Price Performance

Shares of NYSE LH opened at $227.50 on Tuesday. Laboratory Co. of America Holdings has a 1-year low of $174.20 and a 1-year high of $234.09. The firm has a market capitalization of $19.31 billion, a PE ratio of 30.41 and a beta of 1.04. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.20. The business’s fifty day moving average price is $223.60 and its two-hundred day moving average price is $213.28.

Laboratory Co. of America Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 13th. Shareholders of record on Tuesday, February 27th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 1.27%. The ex-dividend date is Monday, February 26th. Laboratory Co. of America’s dividend payout ratio (DPR) is 38.50%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Barclays started coverage on shares of Laboratory Co. of America in a research note on Wednesday, January 3rd. They set an “equal weight” rating and a $222.00 price objective on the stock. Evercore ISI began coverage on shares of Laboratory Co. of America in a research report on Friday. They issued an “in-line” rating and a $240.00 price objective for the company. TheStreet raised Laboratory Co. of America from a “c+” rating to a “b-” rating in a research report on Thursday, January 18th. JPMorgan Chase & Co. increased their price target on Laboratory Co. of America from $259.00 to $261.00 and gave the company an “overweight” rating in a report on Friday, November 17th. Finally, Mizuho dropped their price objective on Laboratory Co. of America from $257.00 to $230.00 and set a “buy” rating on the stock in a report on Tuesday, October 31st. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $241.86.

View Our Latest Analysis on Laboratory Co. of America

Insider Buying and Selling at Laboratory Co. of America

In other Laboratory Co. of America news, EVP Der Vaart Sandra D. Van sold 259 shares of Laboratory Co. of America stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $222.06, for a total transaction of $57,513.54. Following the sale, the executive vice president now owns 7,637 shares of the company’s stock, valued at approximately $1,695,872.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Der Vaart Sandra D. Van sold 259 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $222.06, for a total transaction of $57,513.54. Following the transaction, the executive vice president now owns 7,637 shares in the company, valued at $1,695,872.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Peter J. Wilkinson sold 1,384 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $210.71, for a total value of $291,622.64. Following the completion of the sale, the chief accounting officer now owns 2,087 shares of the company’s stock, valued at $439,751.77. The disclosure for this sale can be found here. 0.65% of the stock is owned by company insiders.

About Laboratory Co. of America

(Free Report)

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development.

See Also

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Co. of America Holdings (NYSE:LHFree Report).

Institutional Ownership by Quarter for Laboratory Co. of America (NYSE:LH)

Receive News & Ratings for Laboratory Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Co. of America and related companies with MarketBeat.com's FREE daily email newsletter.